187 related articles for article (PubMed ID: 34196899)
1. Medication use and mammographic breast density.
Han Y; Lee CT; Xu S; Mi X; Phillip CR; Salazar AS; Rakhmankulova M; Toriola AT
Breast Cancer Res Treat; 2021 Sep; 189(2):585-592. PubMed ID: 34196899
[TBL] [Abstract][Full Text] [Related]
2. Effects of statin use on volumetric mammographic density: results from the KARMA study.
Skarping I; Brand JS; Hall P; Borgquist S
BMC Cancer; 2015 May; 15():435. PubMed ID: 26016855
[TBL] [Abstract][Full Text] [Related]
3. Milk intake and mammographic density in premenopausal women.
Han Y; Zong X; Li Y; Colditz GA; Toriola AT
Breast Cancer Res Treat; 2019 Feb; 174(1):249-255. PubMed ID: 30456438
[TBL] [Abstract][Full Text] [Related]
4. Circulating Receptor Activator of Nuclear Factor-κB (RANK), RANK ligand (RANKL), and Mammographic Density in Premenopausal Women.
Toriola AT; Appleton CM; Zong X; Luo J; Weilbaecher K; Tamimi RM; Colditz GA
Cancer Prev Res (Phila); 2018 Dec; 11(12):789-796. PubMed ID: 30352839
[TBL] [Abstract][Full Text] [Related]
5. Current regular aspirin use and mammographic breast density: a cross-sectional analysis considering concurrent statin and metformin use.
Acheampong T; Lee Argov EJ; Terry MB; Rodriguez CB; Agovino M; Wei Y; Athilat S; Tehranifar P
Cancer Causes Control; 2022 Mar; 33(3):363-371. PubMed ID: 35022893
[TBL] [Abstract][Full Text] [Related]
6. Hormone and receptor activator of NF-κB (RANK) pathway gene expression in plasma and mammographic breast density in postmenopausal women.
Mintz R; Wang M; Xu S; Colditz GA; Markovic C; Toriola AT
Breast Cancer Res; 2022 Apr; 24(1):28. PubMed ID: 35422057
[TBL] [Abstract][Full Text] [Related]
7. Independent and joint cross-sectional associations of statin and metformin use with mammographic breast density.
Lee Argov EJ; Acheampong T; Terry MB; Rodriguez CB; Agovino M; Wei Y; Athilat S; Tehranifar P
Breast Cancer Res; 2020 Sep; 22(1):99. PubMed ID: 32933550
[TBL] [Abstract][Full Text] [Related]
8. Lipidome of mammographic breast density in premenopausal women.
Getz KR; Jeon MS; Luo C; Luo J; Toriola AT
Breast Cancer Res; 2023 Oct; 25(1):121. PubMed ID: 37814330
[TBL] [Abstract][Full Text] [Related]
9. Adiposity Change Over the Life Course and Mammographic Breast Density in Postmenopausal Women.
Han Y; Berkey CS; Herman CR; Appleton CM; Alimujiang A; Colditz GA; Toriola AT
Cancer Prev Res (Phila); 2020 May; 13(5):475-482. PubMed ID: 32102947
[TBL] [Abstract][Full Text] [Related]
10. Family History of Breast Cancer and Mammographic Breast Density in Premenopausal Women.
Han Y; Moore JX; Colditz GA; Toriola AT
JAMA Netw Open; 2022 Feb; 5(2):e2148983. PubMed ID: 35175341
[TBL] [Abstract][Full Text] [Related]
11. Associations of Vitamins and Related Cofactor Metabolites with Mammographic Breast Density in Premenopausal Women.
Matthew KA; Getz KR; Jeon MS; Luo C; Luo J; Toriola AT
J Nutr; 2024 Feb; 154(2):424-434. PubMed ID: 38122846
[TBL] [Abstract][Full Text] [Related]
12. Adiposity during early adulthood, changes in adiposity during adulthood, attained adiposity, and mammographic density among premenopausal women.
Alimujiang A; Appleton C; Colditz GA; Toriola AT
Breast Cancer Res Treat; 2017 Nov; 166(1):197-206. PubMed ID: 28702890
[TBL] [Abstract][Full Text] [Related]
13. Associations of aspirin and other anti-inflammatory medications with mammographic breast density and breast cancer risk.
Yaghjyan L; Wijayabahu A; Eliassen AH; Colditz G; Rosner B; Tamimi RM
Cancer Causes Control; 2020 Sep; 31(9):827-837. PubMed ID: 32476101
[TBL] [Abstract][Full Text] [Related]
14. Breastfeeding and Mammographic Breast Density: A Cross-sectional Study.
Getz KR; Adedokun B; Xu S; Toriola AT
Cancer Prev Res (Phila); 2023 Jun; 16(6):353-361. PubMed ID: 36930943
[TBL] [Abstract][Full Text] [Related]
15. The combined effect of mammographic texture and density on breast cancer risk: a cohort study.
Wanders JOP; van Gils CH; Karssemeijer N; Holland K; Kallenberg M; Peeters PHM; Nielsen M; Lillholm M
Breast Cancer Res; 2018 May; 20(1):36. PubMed ID: 29720220
[TBL] [Abstract][Full Text] [Related]
16. Adiposity at Age 10 and Mammographic Density among Premenopausal Women.
Alimujiang A; Imm KR; Appleton CM; Colditz GA; Berkey CS; Toriola AT
Cancer Prev Res (Phila); 2018 May; 11(5):287-294. PubMed ID: 29500187
[TBL] [Abstract][Full Text] [Related]
17. Predictors of mammographic density among women with a strong family history of breast cancer.
Moran O; Eisen A; Demsky R; Blackmore K; Knight JA; Panchal S; Ginsburg O; Zbuk K; Yaffe M; Metcalfe KA; Narod SA; Kotsopoulos J
BMC Cancer; 2019 Jun; 19(1):631. PubMed ID: 31242899
[TBL] [Abstract][Full Text] [Related]
18. Automated measurement of volumetric mammographic density: a tool for widespread breast cancer risk assessment.
Brand JS; Czene K; Shepherd JA; Leifland K; Heddson B; Sundbom A; Eriksson M; Li J; Humphreys K; Hall P
Cancer Epidemiol Biomarkers Prev; 2014 Sep; 23(9):1764-72. PubMed ID: 25012995
[TBL] [Abstract][Full Text] [Related]
19. Long-term exposure to insulin and volumetric mammographic density: observational and genetic associations in the Karma study.
Borgquist S; Rosendahl AH; Czene K; Bhoo-Pathy N; Dorkhan M; Hall P; Brand JS
Breast Cancer Res; 2018 Aug; 20(1):93. PubMed ID: 30092829
[TBL] [Abstract][Full Text] [Related]
20. Breast Cancer Risk and Mammographic Density Assessed with Semiautomated and Fully Automated Methods and BI-RADS.
Jeffers AM; Sieh W; Lipson JA; Rothstein JH; McGuire V; Whittemore AS; Rubin DL
Radiology; 2017 Feb; 282(2):348-355. PubMed ID: 27598536
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
